VOR — VOR BIOPHARMA INC
As of Q2 2026, 26 SEC-registered investment managers reported holding VOR (VOR BIOPHARMA INC) in their latest 13F filings, with a combined reported value of $223.81M across 12.20M shares. That is +123.8% by share count (+6.75M shares) versus the previous quarter, while reported value moved +130.2%. Ownership is concentrated: the five largest holders account for 85.4% of reported value and the top ten for 94.6%.
Compared with the prior quarter, 9 opened new positions, 14 added to existing stakes, 3 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
VOR is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) history | Q2 2026 | 4.93M | $90.80M | 0.00% | Add |
| BlackRock Inc history | Q2 2026 | 3.47M | $63.85M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 1.06M | $19.56M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 770.25K | $10.07M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 493.28K | $9.08M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 428.07K | $7.88M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 328.89K | $6.05M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 328.74K | $6.05M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 177.74K | $3.27M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 160.41K | $2.95M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 121.40K | $2.23M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 97.72K | $1.80M | 0.00% | New |
| Marshall Wace history | Q2 2026 | 95.64K | $1.76M | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 68.30K | $1.26M | 0.00% | Add |
| Citigroup Inc history | Q2 2026 | 63.13K | $1.16M | 0.00% | Add |
| Morgan Stanley history | Q2 2026 | 61.56K | $1.13M | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 54.67K | $1.01M | 0.00% | New |
| Deutsche Bank AG history | Q2 2026 | 40.35K | $742.86K | 0.00% | New |
| Two Sigma Investments history | Q2 2026 | 37.01K | $681.39K | 0.00% | New |
| Wells Fargo & Co history | Q2 2026 | 36.27K | $667.79K | 0.00% | Add |
New Positions (Q2 2026)
- BNY Mellon 97.72K sh · $1.80M
- D. E. Shaw & Co 54.67K sh · $1.01M
- Deutsche Bank AG 40.35K sh · $742.86K
- Two Sigma Investments 37.01K sh · $681.39K
- Wellington Management Group 27.10K sh · $498.91K
- JPMorgan Chase & Co 21.62K sh · $402.15K
- Manulife Financial 10.79K sh · $198.70K
- Legal & General Investment Management America 8.01K sh · $147.48K
- T. Rowe Price Associates 41.81K sh · $770
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 236.51K | 2.53M | 1.54M | 4.93M |
| BlackRock Inc | 34.53K | 465.64K | 794.76K | 3.47M |
| Geode Capital Management | 27.39K | 185.81K | 342.57K | 1.06M |
| UBS Group AG | 75.91K | 292.12K | 488.37K | 493.28K |
| Millennium Management | 24.76K | 224.53K | 258.59K | 428.07K |
| Goldman Sachs Group | 15.79K | 145.64K | 261.89K | 328.89K |
| Northern Trust Corp | — | 38.95K | 64.55K | 328.74K |
| Bank of America Corp | 4.75K | 396 | 112.89K | 177.74K |
| Citadel Advisors | 25.33K | 462.78K | 148.77K | 160.41K |
| Charles Schwab Investment Management | — | — | 22.22K | 121.40K |
| BNY Mellon | — | — | — | 97.72K |
| Marshall Wace | — | — | 1.15M | 95.64K |
| Invesco Ltd | — | — | 11.60K | 68.30K |
| Citigroup Inc | — | 6.34K | 5.37K | 63.13K |
| Morgan Stanley | 4.46K | 28.46K | 116.72K | 61.56K |
| D. E. Shaw & Co | — | — | — | 54.67K |
| Deutsche Bank AG | — | — | — | 40.35K |
| Two Sigma Investments | — | — | — | 37.01K |
| Wells Fargo & Co | 1 | 1 | 1 | 36.27K |
| Renaissance Technologies | 14.60K | — | 128.84K | 33.01K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details